Correlation Between Neuropace and Biomerica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Biomerica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Biomerica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Biomerica, you can compare the effects of market volatilities on Neuropace and Biomerica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Biomerica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Biomerica.

Diversification Opportunities for Neuropace and Biomerica

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Neuropace and Biomerica is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Biomerica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomerica and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Biomerica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomerica has no effect on the direction of Neuropace i.e., Neuropace and Biomerica go up and down completely randomly.

Pair Corralation between Neuropace and Biomerica

Given the investment horizon of 90 days Neuropace is expected to generate 1.39 times less return on investment than Biomerica. But when comparing it to its historical volatility, Neuropace is 1.72 times less risky than Biomerica. It trades about 0.01 of its potential returns per unit of risk. Biomerica is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  86.00  in Biomerica on November 3, 2024 and sell it today you would lose (36.00) from holding Biomerica or give up 41.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Biomerica

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Biomerica 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Biomerica are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Biomerica sustained solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and Biomerica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Biomerica

The main advantage of trading using opposite Neuropace and Biomerica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Biomerica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerica will offset losses from the drop in Biomerica's long position.
The idea behind Neuropace and Biomerica pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets